{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:24:34Z","timestamp":1794255874544,"version":"4.9.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12325-026-03766-2","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T10:22:07Z","timestamp":1787394127000},"page":"5159-5176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intrawound Vancomycin Powder in Surgical Site Infection Prophylaxis: A Comprehensive Review of Mechanisms, Efficacy, Safety, and Clinical Controversies"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-7860","authenticated-orcid":false,"given":"Alaa","family":"Abd-Elsayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9305-9439","authenticated-orcid":false,"given":"Marco P.","family":"Troka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus Lopez","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8008-5997","authenticated-orcid":false,"given":"Anthony I.","family":"Riad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano Lo","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2464-0187","authenticated-orcid":false,"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8828-7740","authenticated-orcid":false,"given":"Madelyn J.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"issue":"2","key":"3766_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.20408\/jti.2025.0019","volume":"38","author":"AR Rezaei","year":"2025","unstructured":"Rezaei AR, Zienkiewicz D, Rezaei AR. Surgical site infections: a comprehensive review. J Trauma Inj. 2025;38(2):71\u201381. https:\/\/doi.org\/10.20408\/jti.2025.0019.","journal-title":"J Trauma Inj"},{"issue":"7","key":"3766_CR2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42493","volume":"15","author":"F Costabella","year":"2023","unstructured":"Costabella F, Patel KB, Adepoju AV, et al. Healthcare cost and outcomes associated with surgical site infection and patient outcomes in low- and middle-income countries. Cureus. 2023;15(7):e42493. https:\/\/doi.org\/10.7759\/cureus.42493.","journal-title":"Cureus"},{"issue":"2","key":"3766_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/OI9.0000000000000474","volume":"9","author":"TB Puga","year":"2026","unstructured":"Puga TB, Box MW, Lam A, et al. Use of intraoperative vancomycin powder and its effects on the incidence of surgical site infection in orthopaedic trauma: a systematic review with meta-analysis. OTA Int. 2026;9(2):e474. https:\/\/doi.org\/10.1097\/OI9.0000000000000474.","journal-title":"OTA Int"},{"issue":"8","key":"3766_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.5312\/wjo.v14.i8.589","volume":"14","author":"F Mancino","year":"2023","unstructured":"Mancino F, Yates PJ, Clark B, Jones CW. Use of topical vancomycin powder in total joint arthroplasty: why the current literature is inconsistent? World J Orthop. 2023;14(8):589\u201397. https:\/\/doi.org\/10.5312\/wjo.v14.i8.589.","journal-title":"World J Orthop"},{"issue":"1","key":"3766_CR5","doi-asserted-by":"publisher","DOI":"10.5812\/ijpr-160885","volume":"24","author":"M Tabarzad","year":"2025","unstructured":"Tabarzad M, Torshabi M, Heidari M, Haeri A, Mortazavi SM. Vancomycin insights: an update on mechanism, activity, toxicity, resistance, and novel drug delivery systems. Iran J Pharm Res IJPR. 2025;24(1):e160885. https:\/\/doi.org\/10.5812\/ijpr-160885.","journal-title":"Iran J Pharm Res IJPR"},{"issue":"7","key":"3766_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0160187","volume":"11","author":"C Loc-Carrillo","year":"2016","unstructured":"Loc-Carrillo C, Wang C, Canden A, Burr M, Agarwal J. Local intramedullary delivery of vancomycin can prevent the development of long bone Staphylococcus aureus infection. PLoS ONE. 2016;11(7):e0160187. https:\/\/doi.org\/10.1371\/journal.pone.0160187.","journal-title":"PLoS ONE"},{"key":"3766_CR7","volume-title":"Statpearls","author":"S Patel","year":"2026","unstructured":"Patel S, Preuss CV, Bernice F. Vancomycin. In: Statpearls. StatPearls Publishing; 2026."},{"issue":"11","key":"3766_CR8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1302\/2046-3758.911.BJR-2020-0190.R2","volume":"9","author":"H Xu","year":"2020","unstructured":"Xu H, Yang J, Xie J, et al. Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty. Bone Joint Res. 2020;9(11):778\u201388. https:\/\/doi.org\/10.1302\/2046-3758.911.BJR-2020-0190.R2.","journal-title":"Bone Joint Res"},{"issue":"8","key":"3766_CR9","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.arth.2019.03.071","volume":"34","author":"ND Heckmann","year":"2019","unstructured":"Heckmann ND, Mayfield CK, Culvern CN, Oakes DA, Lieberman JR, Della Valle CJ. Systematic review and meta-analysis of intrawound vancomycin in total hip and total knee arthroplasty: a call for a prospective randomized trial. J Arthroplasty. 2019;34(8):1815\u201322. https:\/\/doi.org\/10.1016\/j.arth.2019.03.071.","journal-title":"J Arthroplasty"},{"issue":"1","key":"3766_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/JS9.0000000000001846","volume":"111","author":"B Han","year":"2025","unstructured":"Han B, Lu H, Pan A, et al. Safety and efficacy of intrawound vancomycin powder in the prevention of lumbar surgical site infection: a prospective, double-blind, randomized controlled study. Int J Surg. 2025;111(1):589\u201396. https:\/\/doi.org\/10.1097\/JS9.0000000000001846.","journal-title":"Int J Surg"},{"issue":"22","key":"3766_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14228124","volume":"14","author":"J Suszczy\u0144ska","year":"2025","unstructured":"Suszczy\u0144ska J, Grabala M, Grabala P. Modulation of surgical site infection risk in spinal and thoracic surgeries through operative parameters: a narrative review. J Clin Med. 2025;14(22):8124. https:\/\/doi.org\/10.3390\/jcm14228124.","journal-title":"J Clin Med"},{"issue":"6","key":"3766_CR12","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1007\/s11999-013-3158-5","volume":"472","author":"WWG Ee","year":"2014","unstructured":"Ee WWG, Lau WLJ, Yeo W, Von Bing Y, Yue WM. Does minimally invasive surgery have a lower risk of surgical site infections compared with open spinal surgery? Clin Orthop. 2014;472(6):1718\u201324. https:\/\/doi.org\/10.1007\/s11999-013-3158-5.","journal-title":"Clin Orthop"},{"key":"3766_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/IDR.S390837","volume":"16","author":"W Hu","year":"2023","unstructured":"Hu W, Wang H, Wu X, et al. Does the microflora of surgery site infection change after prophylactic use of vancomycin powder in the spine surgery. Infect Drug Resist. 2023;16:105\u201313. https:\/\/doi.org\/10.2147\/IDR.S390837.","journal-title":"Infect Drug Resist"},{"issue":"5","key":"3766_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.7259","volume":"156","author":"The Major Extremity Trauma Research Consortium (METRC)","year":"2021","unstructured":"The Major Extremity Trauma Research Consortium (METRC). Effect of intrawound vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial. JAMA Surg. 2021;156(5):e207259. https:\/\/doi.org\/10.1001\/jamasurg.2020.7259.","journal-title":"JAMA Surg"},{"issue":"5","key":"3766_CR15","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1097\/JS9.0000000000002316","volume":"111","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Tung TH, Su Y, Li Y, Luo H. Intrawound vancomycin powder for prevention of surgical site infections in primary joint arthroplasty: an umbrella review of systematic reviews and meta-analyses. Int J Surg Lond Engl. 2025;111(5):3508\u201324. https:\/\/doi.org\/10.1097\/JS9.0000000000002316.","journal-title":"Int J Surg Lond Engl"},{"issue":"7","key":"3766_CR16","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.arth.2022.03.047","volume":"37","author":"K Movassaghi","year":"2022","unstructured":"Movassaghi K, Wang JC, Gettleman BS, et al. Systematic review and meta-analysis of intrawound vancomycin in total hip and total knee arthroplasty: a continued call for a prospective randomized trial. J Arthroplasty. 2022;37(7):1405-1415.e1. https:\/\/doi.org\/10.1016\/j.arth.2022.03.047.","journal-title":"J Arthroplasty"},{"key":"3766_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.wneu.2018.10.168","volume":"123","author":"R Bokhari","year":"2019","unstructured":"Bokhari R, You E, Zeiler FA, et al. Effect of intrawound vancomycin on surgical site infections in nonspinal neurosurgical procedures: a systematic review and meta-analysis. World Neurosurg. 2019;123:409-417.e7. https:\/\/doi.org\/10.1016\/j.wneu.2018.10.168.","journal-title":"World Neurosurg"},{"key":"3766_CR18","unstructured":"Deora H, Nagesh M, Garg K, Singh M, Chandra SP, Kale SS. Topical vancomycin for prevention of surgical site infection in cranial surgeries: results of an updated systematic review, meta-analysis and meta-regression. PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/37929420\/. Accessed July 24, 2026"},{"key":"3766_CR19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.91183","author":"AE Mohamad","year":"2025","unstructured":"Mohamad AE, Eid S, Msheik A, et al. Effect of topical vancomycin powder on surgical site infections in cranioplasty: a systematic review and meta-analysis. Cureus. 2025. https:\/\/doi.org\/10.7759\/cureus.91183.","journal-title":"Cureus."},{"issue":"5","key":"3766_CR20","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.surg.2023.05.031","volume":"174","author":"M Kowalewski","year":"2023","unstructured":"Kowalewski M, Pasierski M, Makhoul M, et al. Topical vancomycin for sternal wound infection prophylaxis. A systematic review and updated meta-analysis of over 40,000 cardiac surgery patients. Surgery. 2023;174(5):1102\u201312. https:\/\/doi.org\/10.1016\/j.surg.2023.05.031.","journal-title":"Surgery"},{"key":"3766_CR21","volume":"25","author":"QL Carr","year":"2025","unstructured":"Carr QL, Connor CH, Cantrell R, et al. Replacing bacitracin with vancomycin in adams triple antibiotic solution for irrigation in breast implant reconstruction: a retrospective review of 277 reconstructions. Eplasty. 2025;25:e35.","journal-title":"Eplasty"},{"issue":"10","key":"3766_CR22","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_661_19","volume":"8","author":"G Singh","year":"2019","unstructured":"Singh G, Passi D, Daga D, Manas A, Vignesh U, Bhave SM. Study of antibiotic efficacy of topical vancomycin powder in treatment of infected mandibular fractures and soft tissue surgical site infections. J Fam Med Prim Care. 2019;8(10):3340. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_661_19.","journal-title":"J Fam Med Prim Care"},{"key":"3766_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2025.101765","volume":"59","author":"JB DiSilvestro","year":"2025","unstructured":"DiSilvestro JB, Zitek E, Robison K, et al. The effect of intrawound vancomycin powder on surgical site infection in inguinal lymph node dissection: a randomized controlled trial pilot study. Gynecol Oncol Rep. 2025;59:101765. https:\/\/doi.org\/10.1016\/j.gore.2025.101765.","journal-title":"Gynecol Oncol Rep"},{"key":"3766_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jhin.2024.04.028","volume":"150","author":"N Saka","year":"2024","unstructured":"Saka N, Yamada K, Ono K, et al. Effect of topical vancomycin powder on surgical site infection prevention in major orthopaedic surgery: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. J Hosp Infect. 2024;150:105\u201313. https:\/\/doi.org\/10.1016\/j.jhin.2024.04.028.","journal-title":"J Hosp Infect"},{"issue":"4","key":"3766_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1302\/2633-1462.34.BJO-2022-0009.R1","volume":"3","author":"NN O\u2019Hara","year":"2022","unstructured":"O\u2019Hara NN, Carullo J, Joshi M, et al. Does cumulative topical antibiotic powder use increase the risk of drug induced acute kidney injury in fracture patients? Bone Jt Open. 2022;3(4):284\u201390. https:\/\/doi.org\/10.1302\/2633-1462.34.BJO-2022-0009.R1.","journal-title":"Bone Jt Open"},{"issue":"6","key":"3766_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.5194\/jbji-10-609-2025","volume":"10","author":"J Beschauner","year":"2025","unstructured":"Beschauner J, Felsberg M, Zeh A, Delank KS, Gutteck N, Werneburg F. Renal safety of intraoperative local vancomycin powder application in orthopedic surgery: a retrospective analysis. J Bone Jt Infect. 2025;10(6):609\u201315. https:\/\/doi.org\/10.5194\/jbji-10-609-2025.","journal-title":"J Bone Jt Infect"},{"issue":"5","key":"3766_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/BOT.0000000000001136","volume":"32","author":"JP Hovis","year":"2018","unstructured":"Hovis JP, Montalvo R, Marinos D, et al. Intraoperative vancomycin powder reduces Staphylococcus aureus surgical site infections and biofilm formation on fixation implants in a rabbit model. J Orthop Trauma. 2018;32(5):263\u20138. https:\/\/doi.org\/10.1097\/BOT.0000000000001136.","journal-title":"J Orthop Trauma"},{"issue":"4","key":"3766_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042052","volume":"23","author":"WC Kan","year":"2022","unstructured":"Kan WC, Chen YC, Wu VC, Shiao CC. Vancomycin-associated acute kidney injury: a narrative review from pathophysiology to clinical application. Int J Mol Sci. 2022;23(4):2052. https:\/\/doi.org\/10.3390\/ijms23042052.","journal-title":"Int J Mol Sci"},{"issue":"24","key":"3766_CR29","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1097\/BRS.0b013e3181ff2cb1","volume":"36","author":"FA Sweet","year":"2011","unstructured":"Sweet FA, Roh M, Sliva C. Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine. 2011;36(24):2084\u20138. https:\/\/doi.org\/10.1097\/BRS.0b013e3181ff2cb1.","journal-title":"Spine"},{"issue":"11","key":"3766_CR30","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1016\/j.spinee.2014.03.011","volume":"14","author":"O Emohare","year":"2014","unstructured":"Emohare O, Ledonio CG, Hill BW, Davis RA, Polly DW, Kang MM. Cost savings analysis of intrawound vancomycin powder in posterior spinal surgery. Spine J. 2014;14(11):2710\u20135. https:\/\/doi.org\/10.1016\/j.spinee.2014.03.011.","journal-title":"Spine J"},{"issue":"22","key":"3766_CR31","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1097\/BRS.0000000000000533","volume":"39","author":"AA Theologis","year":"2014","unstructured":"Theologis AA, Demirkiran G, Callahan M, Pekmezci M, Ames C, Deviren V. Local intrawound vancomycin powder decreases the risk of surgical site infections in complex adult deformity reconstruction: a cost analysis. Spine. 2014;39(22):1875\u201380. https:\/\/doi.org\/10.1097\/BRS.0000000000000533.","journal-title":"Spine"},{"issue":"1","key":"3766_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21037\/jss-25-38","volume":"12","author":"JEG V\u00e1squez","year":"2026","unstructured":"V\u00e1squez JEG, P\u00e1ez MGS, Amado AM, Poblete J, Holmgren P. Local vancomycin powder reduces surgical site infections and costs in spine surgery: a retrospective cohort study in a public hospital in Santiago, Chile. J Spine Surg. 2026;12(1):7. https:\/\/doi.org\/10.21037\/jss-25-38.","journal-title":"J Spine Surg"},{"key":"3766_CR33","unstructured":"Nam HH, Martinazzi BJ, Kirchner GJ, et al. Vancomycin powder is highly cost-effective in total ankle arthroplasty. PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/37340880\/. Accessed July 24, 2026"},{"issue":"1","key":"3766_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.12998\/wjcc.v10.i1.71","volume":"10","author":"MY Duan","year":"2022","unstructured":"Duan MY, Zhang HZ. Vancomycin lavage for the incidence of acute surgical site infection following primary total hip arthroplasty and total knee arthroplasty. World J Clin Cases. 2022;10(1):71\u20138. https:\/\/doi.org\/10.12998\/wjcc.v10.i1.71.","journal-title":"World J Clin Cases"},{"issue":"1","key":"3766_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/OI9.0000000000000223","volume":"6","author":"LS Marchand","year":"2023","unstructured":"Marchand LS, Sprague S, O\u2019Hara NN, et al. Local administration of vancomycin powder in orthopaedic fracture surgery: current practice and trends. OTA Int Open Access J Orthop Trauma. 2023;6(1):e223. https:\/\/doi.org\/10.1097\/OI9.0000000000000223.","journal-title":"OTA Int Open Access J Orthop Trauma"},{"issue":"6","key":"3766_CR36","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/17453674.2018.1501548","volume":"89","author":"M Bue","year":"2018","unstructured":"Bue M, Hanberg P, T\u00f8ttrup M, et al. Vancomycin concentrations in the cervical spine after intravenous administration: results from an experimental pig study. Acta Orthop. 2018;89(6):683\u20138. https:\/\/doi.org\/10.1080\/17453674.2018.1501548.","journal-title":"Acta Orthop"},{"issue":"19","key":"3766_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910243","volume":"22","author":"EC Rodr\u00edguez-Merch\u00e1n","year":"2021","unstructured":"Rodr\u00edguez-Merch\u00e1n EC, Davidson DJ, Liddle AD. Recent strategies to combat infections from biofilm-forming bacteria on orthopaedic implants. Int J Mol Sci. 2021;22(19):10243. https:\/\/doi.org\/10.3390\/ijms221910243.","journal-title":"Int J Mol Sci"},{"key":"3766_CR38","unstructured":"Vancomycin and Cefazolin Used Together for Prophylaxis? Medscape. https:\/\/www.medscape.com\/viewarticle\/811262. Accessed May 2, 2026"},{"issue":"2","key":"3766_CR39","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1067\/mtc.2002.119698","volume":"123","author":"R Finkelstein","year":"2002","unstructured":"Finkelstein R, Rabino G, Mashiah T, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg. 2002;123(2):326\u201332. https:\/\/doi.org\/10.1067\/mtc.2002.119698.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"3766_CR40","unstructured":"Does intra-wound vancomycin application during spinal surgery increase rates of surgical wound infection and disruption?\u2014Surgical Infection Society. https:\/\/sisna.org\/does-intra-wound-vancomycin-application-during-spinal-surgery-increase-rates-of-surgical-wound-infection-and-disruption\/. Accessed May 2, 2026"},{"issue":"4","key":"3766_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/BOT.0000000000002767","volume":"38","author":"M Joshi","year":"2024","unstructured":"Joshi M, O\u2019Toole RV, Carlini AR, et al. Does topical vancomycin powder use in fracture surgery change bacteriology and antibiotic susceptibilities? An analysis of the VANCO trial. J Orthop Trauma. 2024;38(4):183. https:\/\/doi.org\/10.1097\/BOT.0000000000002767.","journal-title":"J Orthop Trauma"},{"key":"3766_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1749-7922-9-55","volume":"9","author":"MT Giesecke","year":"2014","unstructured":"Giesecke MT, Schwabe P, Wichlas F, Trampuz A, Kleber C. Impact of high prevalence of pseudomonas and polymicrobial gram-negative infections in major sub-\/total traumatic amputations on empiric antimicrobial therapy: a retrospective study. World J Emerg Surg. 2014;9:55. https:\/\/doi.org\/10.1186\/1749-7922-9-55.","journal-title":"World J Emerg Surg"},{"issue":"2","key":"3766_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02506-21","volume":"10","author":"J Chen","year":"2022","unstructured":"Chen J, Cao Z, Cannon J, Fan Y, Baker JR, Wang SH. Effective treatment of skin wounds co-infected with multidrug-resistant bacteria with a novel nanoemulsion. Microbiol Spectr. 2022;10(2):e02506-21. https:\/\/doi.org\/10.1128\/spectrum.02506-21.","journal-title":"Microbiol Spectr"},{"issue":"3","key":"3766_CR44","doi-asserted-by":"publisher","first-page":"710","DOI":"10.4103\/ajns.AJNS_294_17","volume":"14","author":"S Kunakornsawat","year":"2019","unstructured":"Kunakornsawat S, Sirikajohnirun S, Piyaskulkaew C, et al. Comparison between 1 g and 2 g of intrawound vancomycin powder application for prophylaxis in posterior instrumented thoracic or lumbosacral spine surgery: a preliminary report. Asian J Neurosurg. 2019;14(3):710\u20134. https:\/\/doi.org\/10.4103\/ajns.AJNS_294_17.","journal-title":"Asian J Neurosurg"},{"key":"3766_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.xnsj.2026.100933","author":"LF Panzenb\u00f6ck","year":"2026","unstructured":"Panzenb\u00f6ck LF, Nour GA, D\u00fcrrschnabel DL, Pallamar M, Krepler P. Serum and local vancomycin concentrations following intrawound application in elective lumbar spinal fusion: a secondary pharmacokinetic analysis of the vancomycin arm of a prospective randomized controlled trial. North Am Spine Soc J NASSJ. 2026. https:\/\/doi.org\/10.1016\/j.xnsj.2026.100933.","journal-title":"North Am Spine Soc J NASSJ."},{"key":"3766_CR46","unstructured":"Rathbone C, Cross J, Brown K, Murray C, Wenke J. Effect of various concentrations of antibiotics on osteogenic cell viability and activity. PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/21567453\/. Accessed July 24, 2026"},{"key":"3766_CR47","doi-asserted-by":"publisher","DOI":"10.21037\/jeccm.2018.03.02","author":"M Zhou","year":"2018","unstructured":"Zhou M, Xu C, Yu Y. Local vancomycin powder administration is not the holy grail, only on the half way there. J Emerg Crit Care Med. 2018. https:\/\/doi.org\/10.21037\/jeccm.2018.03.02.","journal-title":"J Emerg Crit Care Med"},{"issue":"5","key":"3766_CR48","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jmii.2015.07.003","volume":"49","author":"SH Huang","year":"2012","unstructured":"Huang SH, Chen YC, Chuang YC, et al. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: a multicenter surveillance study, 2012-2013. J Microbiol Immunol Infect. 2012;49(5):701\u20137. https:\/\/doi.org\/10.1016\/j.jmii.2015.07.003.","journal-title":"J Microbiol Immunol Infect"},{"key":"3766_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.xnsj.2020.100048","volume":"5","author":"G Xiong","year":"2021","unstructured":"Xiong G, Fogel H, Tobert D, et al. Vancomycin-impregnated calcium sulfate beads compared with vancomycin powder in adult spinal deformity patients undergoing thoracolumbar fusion. North Am Spine Soc J NASSJ. 2021;5:100048. https:\/\/doi.org\/10.1016\/j.xnsj.2020.100048.","journal-title":"North Am Spine Soc J NASSJ"},{"issue":"1","key":"3766_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30951-y","volume":"13","author":"KM Brothers","year":"2023","unstructured":"Brothers KM, Parker DM, Taguchi M, et al. Dose optimization in surgical prophylaxis: sub-inhibitory dosing of vancomycin increases rates of biofilm formation and the rates of surgical site infection. Sci Rep. 2023;13(1):4593. https:\/\/doi.org\/10.1038\/s41598-023-30951-y.","journal-title":"Sci Rep"},{"key":"3766_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jor.2024.02.011","volume":"53","author":"E Thompson","year":"2024","unstructured":"Thompson E, Qureshi A. Pathogens in FRI \u2013 do bugs matter? - An analysis of FRI studies to assess your enemy. J Orthop. 2024;53:59\u201372. https:\/\/doi.org\/10.1016\/j.jor.2024.02.011.","journal-title":"J Orthop"},{"issue":"5","key":"3766_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9050238","volume":"9","author":"J Braun","year":"2020","unstructured":"Braun J, Eckes S, Rommens PM, Schmitz K, Nickel D, Ritz U. Toxic effect of vancomycin on viability and functionality of different cells involved in tissue regeneration. Antibiotics. 2020;9(5):238. https:\/\/doi.org\/10.3390\/antibiotics9050238.","journal-title":"Antibiotics"},{"issue":"1","key":"3766_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/BOT.0000000000001615","volume":"34","author":"WJ Metsemakers","year":"2020","unstructured":"Metsemakers WJ, Fragomen AT, Moriarty TF, et al. Evidence-based recommendations for local antimicrobial strategies and dead space management in fracture-related infection. J Orthop Trauma. 2020;34(1):18\u201329. https:\/\/doi.org\/10.1097\/BOT.0000000000001615.","journal-title":"J Orthop Trauma"},{"issue":"1","key":"3766_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.22603\/ssrr.2016-0002","volume":"2","author":"H Takahashi","year":"2018","unstructured":"Takahashi H, Iida Y, Yokoyama Y, et al. Use of intrawound vancomycin powder against postoperative infection after spine surgery. Spine Surg Relat Res. 2018;2(1):18\u201322. https:\/\/doi.org\/10.22603\/ssrr.2016-0002.","journal-title":"Spine Surg Relat Res"},{"key":"3766_CR55","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1097\/BOT.0000000000000801","volume":"31","author":"RV O\u2019Toole","year":"2017","unstructured":"O\u2019Toole RV, Joshi M, Carlini AR, et al. Local antibiotic therapy to reduce infection after operative treatment of fractures at high risk of infection: a multicenter, randomized, controlled trial (VANCO Study). J Orthop Trauma. 2017;31:S18. https:\/\/doi.org\/10.1097\/BOT.0000000000000801.","journal-title":"J Orthop Trauma"},{"issue":"1","key":"3766_CR56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/BOT.0000000000001863","volume":"35","author":"R Qadir","year":"2021","unstructured":"Qadir R, Costales T, Coale M, et al. Vancomycin powder use in fractures at high risk of surgical site infection. J Orthop Trauma. 2021;35(1):23\u20138. https:\/\/doi.org\/10.1097\/BOT.0000000000001863.","journal-title":"J Orthop Trauma"},{"key":"3766_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-025-09095-z","volume":"26","author":"RT Sch\u00e4r","year":"2025","unstructured":"Sch\u00e4r RT, Branca M, Fischer U, Zimmerli S, S\u00f6ll N. Intrawound vancomycin powder for prevention of surgical site infections after open instrumented posterior spinal fusion (VANCO trial)\u2014methodology of a randomized, controlled, multicenter study. Trials. 2025;26:344. https:\/\/doi.org\/10.1186\/s13063-025-09095-z.","journal-title":"Trials"},{"key":"3766_CR58","unstructured":"Soliman M. The effect of intrawound vancomycin powder in spine surgery: a prospective randomized controlled trial. clinicaltrials.gov. 2024. https:\/\/clinicaltrials.gov\/study\/NCT04825522. Accessed May 3, 2026"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03766-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03766-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03766-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:02:51Z","timestamp":1794254571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03766-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["3766"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03766-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Alaa Abd-Elsayed and Alan David Kaye are Editorial Board members of Advances in Therapy. Alaa Abd-Elsayed and Alan David Kaye were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Alaa Abd-Elsayed is also a consultant for Medtronic, Curonix, Avanos, and Averitas. Marco P. Troka, Jesus Lopez Ortega, Anthony I. Riad, Giuliano Lo Bianco, and Madelyn J. Reilly have no relevant disclosures to report.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}